BEA 2180 BR
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for BEA 2180 BR, covering 2014-09-17 to 2021-08-24. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. [Phase 2]